Adding Tirofiban on Top of Recombinant Tissue Plasminogen Activator May Improve Clinical Outcome in Acute Stroke Patients
Work
Year: 2024
Type: article
Abstract: Stroke remains the leading cause of disability-adjusted life-years and deaths in China. 1 Current guidelines recommend intravenous thrombolysis (IVT) with recombinant tissue plasminogen activator (rt-... more
Source: Journal of Stroke
Institutions Yuhuangding Hospital, Qingdao University, Capital Medical University, Binzhou Medical University, Binzhou University
Cites: 11
Cited by: 3
Related to: 10
FWCI: 2.765
Citation percentile (by year/subfield): 79.6
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: diamond